Results 121 to 130 of about 7,554 (201)

CD160-Derived Peptide as a Bidirectional Inhibitor Toward Immune Checkpoints BTLA/HVEM and HVEM/LIGHT. [PDF]

J Med Chem
Lipińska M, Ciura P, Gumpelmair S, Sikorska E, Kuncewicz K, Sieradzan AK, Steinberger P, Wardowska A, Spodzieja M.   +8 more
europepmc   +1 more source

Association between B and T lymphocyte attenuator/herpes virus entry mediator immunoregulatory axis and outcome prediction in a mixed critically ill population. [PDF]

Sci Rep
Kokkoris S, Theodorou E, Lotsios NS, Keskinidou C, Vrettou CS, Poupouzas G, Issaris V, Premetis I, Kotanidou A, Dimopoulou I, Vassiliou AG.   +10 more
europepmc   +1 more source

BTLA-Expressing Memory B Cells Are Associated with Belimumab-Induced Improvement in Systemic Lupus Erythematosus. [PDF]

Int J Mol Sci
Nishi T, Hayakawa K, Ikeda K, Fujishiro M, Kataoka Y, Yamaji K, Takamori K, Tamura N, Sekigawa I, Morimoto S.   +9 more
europepmc   +1 more source

Immune checkpoint imbalance in ANCA-associated vasculitis: insights into disease activity and precision immunotherapy. [PDF]

Front Med (Lausanne)
García-Serrano L, Martinez-Valenzuela L, Draibe J.   +2 more
europepmc   +1 more source

Smoking-Associated Enrichment of CXCL13⁺ Tfh Cells and VCAM1⁺ Fibroblasts Is Linked to Tertiary Lymphoid Structure Formation in Lung Adenocarcinoma. [PDF]

J Cancer
Choi YJ, Kim CY, Kim EY, Lee SH, Park MK, Chang YS.   +5 more
europepmc   +1 more source

cTfh Cell Activation and Changes in BTLA and LAG-3 Expression Differentially Associate With Poor Pregnancy Outcome in Plasmodium falciparum Placental Malaria. [PDF]

J Immunol Res
Zambo Bitye BM, Mbianda Nana CM, Kwanou Tchakounte BD, Fogang B, Kenfack Tekougang Zangue B, Medouen Ndeumou RS, Ayong L, Megnekou R.   +7 more
europepmc   +1 more source

Soluble immune checkpoints as diagnostic biomarkers in bladder cancer. [PDF]

Biomark Res
Andrzejczak A, Krajewski W, Jaskuła E, Chorbińska J, Tomkiewicz A, Sarat K, Mroczek R, Małkiewicz B, Szydełko T, Karabon L.   +9 more
europepmc   +1 more source

Safety, Tolerability, Pharmacokinetics, and Immunogenicity of a BTLA Agonist Antibody (Venanprubart) in Healthy Participants, Patients with Systemic Lupus Erythematosus, and Patients with Psoriasis: Results From Three Phase 1 Studies. [PDF]

Clin Pharmacol Drug Dev
Vendel AC, Benichou O, Chang CY, Datta G, Ferrante A, Ghosh I, Moser BA, Sweeney SE, Witcher J, Linnik MD.   +9 more
europepmc   +1 more source

Breast and ovarian cancers: toward a multi-cancer early detection test. [PDF]

Front Immunol
Habel A, Bessaad M, Stayoussef M, Xu W, Bouaziz H, Ayadi M, Larbi A, Yaacoubi-Loueslati B.   +7 more
europepmc   +1 more source

The Search for Predictive Biomarkers in Response to Immune Checkpoint Inhibitors and Associated Adverse Events. [PDF]

J Pers Med
Agostini M, Traldi P, Hamdan M.
europepmc   +1 more source